Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2005
03/31/2005CA2538887A1 Measles subunit vaccine
03/31/2005CA2538791A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
03/31/2005CA2538760A1 Human .beta.-defensin secretion promoter
03/31/2005CA2537325A1 Aza-quinolinol phosphonate integrase inhibitor compounds
03/31/2005CA2535645A1 Therapeutic immunization of hiv-infected individuals
03/31/2005CA2523657A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518864A2 Antibody against rhesus D
03/30/2005EP1518557A1 Anti-hiv agent
03/30/2005EP1517924A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
03/30/2005EP1517923A2 Compositions and methods for inhibiting microbial adhesion
03/30/2005EP1517916A2 Peptides having antimicrobial properties and compositions containing same in particular for preserving foods
03/30/2005EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
03/30/2005EP1517904A2 Mitotic kinesin inhibitors
03/30/2005EP1517899A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
03/30/2005EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
03/30/2005EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517696A1 Prevention, therapy and prognosis/monitoring in sepsis and septic shock
03/30/2005EP1517692A1 Method and agent for the prevention, inhibition and treatment of sepsis
03/30/2005EP1517687A1 Medicament for the treatment of the systemic inflammatory response syndrome
03/30/2005EP1392341B1 Pharmaceutical composition containing a stabilised mrna which is optimised for translation in the coding regions thereof
03/30/2005EP1389909A4 Antimicrobial compounds and methods for their use
03/30/2005EP1289998B1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
03/30/2005EP1246692B1 Templating of uncharged solid particles by polymer multilayers
03/30/2005EP1224163B1 Use of carbonylamino derivatives against cns disorders
03/30/2005EP1203088B1 Conditionally controlled, attenuated hiv vaccine
03/30/2005EP1192127B1 Substituted benzamide inhibitors of rhinovirus 3c protease
03/30/2005EP1075467B1 Pyrazole derivatives as p-38 map kinase inhibitors
03/30/2005EP1035844B1 The use of polyols in combating yeast infection and polyol preparations for said use
03/30/2005EP0821584B1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection
03/30/2005EP0791056B1 Lipid-cleavage enzyme complex
03/30/2005EP0788798B1 Antiviral agent and process for preparing the same
03/30/2005CN1602358A Recombinant fusion proteins and the trimers thereof
03/30/2005CN1602316A Flavivirus NS1 subunit vaccine
03/30/2005CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
03/30/2005CN1602308A Thiophene derivatives used as antiviral agent against flavivirus infections
03/30/2005CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents
03/30/2005CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
03/30/2005CN1602216A Microprojection array immunization patch and method
03/30/2005CN1602205A Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
03/30/2005CN1602204A Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
03/30/2005CN1602202A A method for identification and development of therapeutic agents
03/30/2005CN1602200A Plant extract active as an immunostimulating agent
03/30/2005CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
03/30/2005CN1602194A Method for treating retroviral infections
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1602154A Inhibition of the asexual reproduction of fungi
03/30/2005CN1600856A Method for constructing hybridoma cell line of heterogeneity of seereting human monoclonal antibody for anti hepatitis B
03/30/2005CN1600852A Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup B
03/30/2005CN1600791A SARS antigen peptide
03/30/2005CN1600785A Method for preparing unformed cefuroxime axetil
03/30/2005CN1600371A Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium
03/30/2005CN1600369A Method for preparing targeting preparation of human monoclonal antibody crosslinking interferon for anti hepatitis b virus
03/30/2005CN1600368A Attenuated live vaccine of eel vibrio
03/30/2005CN1600353A Extractive of rosemary, preparation method and application
03/30/2005CN1600352A Combination of Chinese traditional medicine for curing common cold and preparation method
03/30/2005CN1600346A Technique of producing injection of Chinese traditional medicine for curing hepatitis
03/30/2005CN1600342A External remedy for curing common cold
03/30/2005CN1600329A Application of 'Kudiezi' injection in use for preparing antiviral remedy
03/30/2005CN1600323A Short corynebacteria pharmaceutics or short corynebacteria pharmaceutics without cells in application for preparing medicine of curing HIV infection or AIDS
03/30/2005CN1600322A Combination of propolis, preparation method and usage
03/30/2005CN1600316A Drop Pills of cucurbitacin medication and preparation method
03/30/2005CN1600315A Soft capsule combination of Cloquinate/Promestriene in use for vagina
03/30/2005CN1600312A Combination of valaciclovir hydrochloride soft capsule
03/30/2005CN1600311A Medication in silkworm use for treating bacteriosis and preparation method
03/30/2005CN1600310A Combination of Liranaftate gelatin and preparation method
03/30/2005CN1600308A Application of l-sophocarpine on preparing medication for curing disease caused by coronavirus
03/30/2005CN1600306A Application of geldanamycin (C-3559) preparation of medicine for curing genital tract infection of condyloma accuminatum and herpes virus and on preparation of medicine for curing poliomyelitis
03/30/2005CN1600303A Application of salvia acid in pharmacy
03/30/2005CN1600301A External remedy for treating psoriasis
03/30/2005CN1600300A Compound external remedy for treating psoriasis
03/30/2005CN1194988C Killer cell antibiosis polypeptide activated lymphokine and its application
03/30/2005CN1194986C Type-c hepatitis virus high-variation-zone 1 synthesized peptide and use thereof
03/30/2005CN1194980C Phosphonocephem derivatives, process for preparation of same, and use thereof
03/30/2005CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments
03/30/2005CN1194977C Tetracyclic fluoroquinolone carboxylic acid, its preparing method and medicinal composition with it as active component
03/30/2005CN1194758C Vaginal lactobacillus medicant
03/30/2005CN1194755C Medicine for treating hepatitis B and its preparation method
03/30/2005CN1194752C Anti-virus Chinese medicine composition and preparation process thereof
03/30/2005CN1194736C Composition for treating hepatitis B
03/30/2005CN1194734C Pill for treating hepatitis B
03/30/2005CN1194722C Shugan Zhitong soft extract for treating hepatitis
03/30/2005CN1194707C Use of lactobacillus casei in immunostimulatory peptides
03/30/2005CN1194705C Natural toad prepared as Chinese medicine for curing AIDS
03/30/2005CN1194700C Globeflower powder for injection and its prepn
03/30/2005CN1194697C Concentrated clear solution containing macrolides drug for intraveenous injection after being diluted
03/30/2005CN1194695C Adfuwei ester soft capsule and its preparation method
03/30/2005CN1194687C Pharmaceutical formulations comprising amoxocyllin and clavulanate
03/30/2005CN1194683C Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method
03/30/2005CN1194676C Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof
03/30/2005CN1194675C Use of trans-3, 4, 5-trihydroxy-diphenyl in preparation of medicine for resisting hepatitis B virus
03/30/2005CN1194673C Anti-Virus arosol inhalation medicine liquid
03/30/2005CN1194666C Preparation of Azthromycin solution and semi-solid
03/29/2005US6872823 Bactericides; chemical intermediates
03/29/2005US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof
03/29/2005US6872805 Hepatitis C virus inhibitors
03/29/2005US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis
1 ... 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 ... 1798